Abstract
BackgroundThe benefit of an early coronary intervention after streptokinase (SK) therapy in low to intermediate-risk patients with ST-elevation myocardial infarction (STEMI) still remains uncertain. The current study aimed to evaluate...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have